FBLG
FibroBiologics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
FibroBiologics (FBLG) Stock: Buy, Sell, or Hold?
$0.97
-0.03 (-2.81%)
âŧ
5d:
+1.16%
30d:
+1.87%
90d:
-8.7%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
50/100
Position
FAIR
30-Day Fair Range
$0.92 â $1.06
Position: FAIR
Forward P/E & Valuation
-2.3x
Next 12M consensus est.
Wall Street Target
$12.50
+1191.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.90 / $1.04
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: FBLG is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When FBLG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: FBLG is currently trading at $0.97, which is considered fair relative to its 30-day fair value range of $0.92 to $1.06.
Technical Outlook: Technically, FBLG is in a uptrend. Immediate support is located at $0.90, while resistance sits at $1.04.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.50 (+1191.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBLG is in a uptrend. Immediate support is located at $0.90, while resistance sits at $1.04.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.50 (+1191.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.92 -
$1.06
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$0.92 -
$1.06
Current vs Trading Range
FAIR
Support Level
$0.90
Resistance Level
$1.04
Current Trend
Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1191.6% below Wall St target ($12.50)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.33
Wall Street Target
$12.50
(+1191.6%)
Share FBLG Analysis
Share this live FBLG analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FBLG)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment dominates on StockTwits regarding $FBLG, with one user expressing intent to buy at lower prices next year for tax purposes.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:51 PM ET
Data refreshes hourly during market hours. Next update: 10:51 PM
Data refreshes hourly during market hours. Next update: 10:51 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBLG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
PVLA
Palvella Therapeutics, IâĻ |
STRONG BUY
16 analysts |
$233 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive FBLG Research Pages
